Cargando…
New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir
The Human Immunodeficiency Virus type 1 protease enzyme (HIV-1 PR) is one of the most important targets of antiretroviral therapy used in the treatment of AIDS patients. The success of protease-inhibitors (PIs), however, is often limited by the emergence of protease mutations that can confer resista...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909182/ https://www.ncbi.nlm.nih.gov/pubmed/24498124 http://dx.doi.org/10.1371/journal.pone.0087520 |